/
/
/

Kilitch Drugs (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)172.80
Volume (₹)9,031.00
High (₹)177.00
Upper Circuit181.14
Low (₹)172.80
Lower Circuit163.90
Prev Close172.52
52W High (₹)219.50
Price175.50
52W Low (₹)117.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)599.77 Cr
Div. Yield (%)0.00
PE Ratio19.96
Debt to Equity0.32
Price to Book1.60
Book Value79.89
EPS (TTM)8.60
Face Value10.00
ROE (%)12.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
KILITCH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1905.6-14.4 (-0.75%)
1902
1984.80
4,56,833Cr
9213.5-25.5 (-0.28%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1133.8-57.2 (-4.80%)
1125.10
1187
1,13,217Cr
1391-32.5 (-2.28%)
1376.70
1426.10
1,12,212Cr
1854.2-84.3 (-4.35%)
1811.70
1949
1,01,155Cr
2122.2-49.3 (-2.27%)
2118.10
2192
97,626Cr
2350.6-32.3 (-1.36%)
2341.20
2419.20
96,859Cr
1163.5-14.5 (-1.23%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
175.5+3.73 (2.17%)
166.15
177.25
600Cr

Key Highlights of Kilitch Drugs (India) Ltd Balance Sheet

Kilitch Drugs (India) Ltd balance sheet discloses shareholders' funds of ₹34.96Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹34.96Cr, and the reserves and surplus of the company is ₹297.69Cr.

The company has its non-current liabilities with total liabilities of ₹494.88Cr as of 2026-03-31.

The current liabilities are ₹107.17Cr as of 2026-03-31. At the same time, current assets are ₹206.14Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹71.89Cr and tangible assets of ₹19.54Cr, provided in the Kilitch Drugs (India) Ltd financial statements.